5. Acetaminophen Protein Adducts
Complex that forms when NAPQI binds to protein
Confined to centrilobular hepatocytes
Don’t occur in periportal hepatocytes
At least 20 molecular adducts have been detected
inside mitochondria, nucleus, and hepatocyte cytosol
From slideshare.net,
occupational-liver-disorders
6. Evidence for Protein Adducts in
Hepatocytes with Toxic Levels of APAP
J.A. Hinson, Adverse
Drug Reactions, 2010
• Acetaminophen cysteine adduct
• At 2–6 h hepatocytes undergoing
necrosis
• By 24 h all the necrotic cells contained
adducts.
7. Evidence for Protein Adducts in
Hepatocytes with Toxic Levels of APAP
J.A. Hinson, Adverse Drug Reactions, 2010
acetaminophen nitrotyrosine
adducts
8. Protein Adducts Cause Oxidative Stress in
Hepatocytes
J.A. Hinson, Chemical
Research in Toxicology,
1998
• Acetaminophen nitrotyrosine
adducts
• Serum samples were analyzed
for ALT (marker of hepatic cell
lysis) and nitrate plus nitrite
levels (marker of Nitric oxide
synthesis).
9. Protein Adducts Trigger Mitochondria
Dysfunction in Hepatocytes
Yuchao Xie,
Toxicological Applied
Pharmacology, 2015
• Human hepatocytes
• Acetaminophen cysteine adducts
10. Toxic Rescue
Only approved antidote for APAP toxicity is oral or intravenous administration of
N-acetyl-cysteine (NAC).
NAC is a precursor in the synthesis of GSH.
Restores the intracellular pool of GSH and neutralizes any residual NAPQI still
present in the liver.
Very effective if administered within the first 8 hours after toxic APAP ingestion.
Many patients wait too long after overdosing.
Liver transplant.
Activation of autophagy may protect against APAP liver toxicity.
11. Conclusion
• APAP is largely metabolized in the liver, predominantly by sulfation and
glucuronidation.
• Approximately 5%–10% of APAP is metabolized primarily by CYP2E1 to the toxic
metabolite N-acetyl-p-benzoquinone imine (NAPQI).
• At therapeutic doses of APAP, NAPQI is immediately inactivated by conjugation with
glutathione (GSH).
• At toxic does of APAP, NAPQI depletes GSH, modifies cellular proteins, and forms
protein adducts.
• Hepatotoxicity caused by liver cell necrosis.
• NAC is only approved antidote for early hepatoxicity,
APAP is largely metabolized in the liver, predominantly by sulfation and glucuronidation
Approximately 5%–10% of APAP is metabolized by cytochrome P450 (CYP), primarily by CYP2E1,11–13 to the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) NAP-KEY.
At therapeutic doses, NAPQI (and oxidant) is immediately inactivated by conjugation with reduced glutathione (GSH). GSH antioxidant.
With over dosage of APAP (NAPQI) depletes GSH and modifies cellular proteins and forms protein adducts
Hepatotoxicity caused by liver cell necrosis
While the glucuronide and sulfate conjugates of APAP are directly excreted in urine, APAP-GSH is initially excreted in bile, degraded in other organs including the kidney (63–64), and the degradation products are ultimately excreted in urine (65).
is a time course for formation of the acetaminophen protein adducts and development of toxicity in individual murine hepatocytes (Roberts et al. 1991). In this assay, the adducts are stained red. Adducts are visible in the liver sections within 15 min of dosing. By 1 h, staining intensity is maximal and adducts are confined to the centrilobular hepatocytes. Adducts do not occur in the periportal hepatocytes. At 2–6 h, hepatocytes containing adducts are undergoing necrotic changes as evidenced by vacuolization and pycnotic changes in the nuclei. Note that the only hepatocytes observed to develop necrosis were those containing acetaminophen-protein adducts. By 24 h, all the necrotic cells contained adducts. The majority of hepatocytes that had acetaminophen-protein adducts were reported to develop necrosis
Acetaminophen cysteine adduct 3-cys-A
Immunohistochemical comparison of cellular localization of acetaminophen-protein adducts to nitrotyrosine in hepatic proteins of mice treated with a toxic dose of acetaminophen. Mice were treated with acetaminophen (300 mg kg−1) or saline and livers removed at 4 h. (b) Liver section was immunochemically stained for nitrotyrosine in protein using an antinitrotyrosine antiserum. (c) Liver section from a saline-treated mouse stained for nitroytrosine in protein using antinitrotyrosine antiserum (Hinson et al. 1998)
Nitrotyrosine is identified as an indicator or marker of cell damage, inflammation as well as NO production.
Immunochemical analysis of liver sections for nitrotyrosine adducts or acetaminophen adducts—found in centrilobular areas of liver
Comparison of acetaminophen-induced hepatotoxicity to nitric oxide formation in mice treated with a toxic dose of acetaminophen. Mice (n ) 6) were treated with acetaminophen (300 mg/kg) and sacrificed at 4 h. Serum samples were analyzed for ALT (marker of hepatic cell lysis) and nitrate plus nitrite levels (marker of Nitric oxide synthesis). The data points are serum levels of ALT and nitrate plus nitrite in the individual mice
APAP triggers GSH depletion, mitochondria dysfunction and protein adduct formation in PHH(
A) Time course of cellular glutathione depletion after 10mM APAP. (B) Loss of mitochondria membrane potential over 24 hours after 10mM APAP, as indicated by decrease of red/green fluorescence ratio using the JC-1 assay. APAP-protein adduct formation (C) in the whole cell and (D) in the mitochondria fraction over 15 hours after 10mM APAP. Data represent mean ± SE from experiments using cells from 3–8 donors. * P < 0.05 (compared with time 0).
Mitochondria generate ATP
Autophagy nutrient starvation lysosomal degradation of cellular contents removal of damaged mitochondria